A Single Dose Oral Excretion Balance Study of [14C]-RPC1063 in Healthy Male Adults

Summary

This will be an open-label, non-randomized, single oral dose study in healthy male subjects. All subjects will receive a single oral dose of 10 mL of \[14C\]-RPC1063 Solution (0.1 mg/mL), containing NMT 1.3 MBq (37 μCi) 14C.

Timeline

Start

2016-10

Primary completion

2016-11

Completion

2016-11

Drugs

Indications

No indication recorded.